| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. | CEO and President, Director | Class A Common Stock | 11.6K | $198K | $17.05 | Apr 4, 2024 | Direct |
| KIORA PHARMACEUTICALS INC | Director | Common Stock | 1.25K | $4.6K | $3.68 | Sep 11, 2024 | Direct |
| Contineum Therapeutics, Inc. | CEO and President, Director | Stock Option (right to buy) | 285K | May 24, 2024 | Direct | ||
| KIORA PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 1.78K | Jul 1, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KPRX | KIORA PHARMACEUTICALS INC | Sep 11, 2024 | 1 | $4.6K | 4 | Sep 12, 2024 | Director |
| KPRX | KIORA PHARMACEUTICALS INC | Jul 1, 2024 | 1 | $0 | 4 | Jul 3, 2024 | Director |
| CTNM | Contineum Therapeutics, Inc. | May 24, 2024 | 1 | $0 | 4 | May 29, 2024 | CEO and President, Director |
| CTNM | Contineum Therapeutics, Inc. | Apr 4, 2024 | 0 | $0 | 3 | Apr 4, 2024 | CEO and President, Director |
| KPRX | KIORA PHARMACEUTICALS INC | Sep 29, 2023 | 1 | $0 | 4 | Oct 3, 2023 | Director |
| KPRX | KIORA PHARMACEUTICALS INC | Aug 1, 2023 | 0 | $0 | 3 | Aug 10, 2023 | Director |